Parse Biosciences logo

Parse Biosciences

Scalable Single Cell Sequencing Without the Instrument

133 employees · est. 2018 · Seattle, United States

VS
Singleron Biotechnologies logo

Singleron Biotechnologies

From single cell multi-omics to precision medicine

90 employees · est. 2018 · Cologne, Germany

Side-by-Side Comparison

Parse Biosciences Singleron Biotechnologies
Founded
2018 2018
Headquarters
Seattle, United States Cologne, Germany
Employees
133 90
Industry
Biotechnology, Life Sciences, Clean Energy Biotechnology
Funding Stage
Acquired Series B
Total Funding
$299.70M $230.00M
Funding Rounds
6 3
Services
Single cell sequencing services, Whole transcriptome analysis, Data analytics for sequencing, Immune profiling (TCR and BCR), Automation of sequencing workflows Single Cell and Single Nucleus Sequencing, Immune Profiling, Bioinformatics Services, eQTL Analysis, Bulk mRNA Sequencing, Single Cell ATAC-seq
Target Customers
Research laboratories, Biotech companies, Academic researchers, Biomedical scientists, Immunologists Clinical Researchers, Biopharma Companies, Academic Institutions, Pharmaceutical Companies, Healthcare Professionals
Taxonomy
Single Cell Sequencing, Combinatorial CDNA Barcoding, Biotechnology Startup, Cancer Research, Tissue Repair, Stem Cell Therapy, Kidney Disease Research, Liver Disease Research, Brain Development Research, Immune System Research, Sample Handling Innovation, Biological Data Analysis, Non-microfluidic Sequencing, Fixed Sample Processing, Scientific Research Acceleration Single Cell Sequencing, Multi-omics, Precision Medicine, Clinical Research, Diagnostics, Drug Development, High-throughput Analysis, Microfluidics, Molecular Diagnosis, Data Sciences, Cancer Research, Health Management, Innovation
Website
parsebiosciences.com singleron.bio
Parse Biosciences logo

About Parse Biosciences

Parse Biosciences, founded in 2018 and headquartered in the United States, is a dynamic player in the Biotechnology and Life Sciences sectors. With a compelling slogan—"Scalable Single Cell Sequencing Without the Instrument"—the company is focused on revolutionizing single cell sequencing. Its innov...

Singleron Biotechnologies logo

About Singleron Biotechnologies

Singleron Biotechnologies, founded in 2018, is a pioneering name in the Biotechnology industry. With a focus on transforming clinical research, diagnostics, and drug development, Singleron leverages high-throughput single-cell analyses to generate rapid and precise research outcomes. Their innovativ...

We will tell you when either one moves

BounceWatch watches Parse Biosciences and Singleron Biotechnologies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Parse Biosciences and Singleron Biotechnolog... — by email.

Frequently Asked Questions

Parse Biosciences — Scalable Single Cell Sequencing Without the Instrument. Singleron Biotechnologies — From single cell multi-omics to precision medicine. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Parse Biosciences has raised $299.70M while Singleron Biotechnologies has raised $230.00M.
Parse Biosciences and Singleron Biotechnologies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Parse Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Parse Biosciences on 15 Jun 2026, and Singleron Biotechnologies on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy